BARDA Archives - EverGlade

BARDA

BARDA Seeks SI-Enabled Ultrasound Devices for Point-of-Care Fracture Detection

All Posts, BARDA, Emerging Technologies, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA) has issued a Sources Sought Notice for Automated Ultrasound-Based, Super Intelligence (SI)-Enabled Fracture Detection. The notice seeks information on commercially available and near-commercial technologies that could support rapid triage of fractures and soft tissue injuries in emergency departments, urgent care centers, and field settings. Responses are due

BARDA Seeks SI-Enabled Ultrasound Devices for Point-of-Care Fracture Detection Read More »

BARDA’s “Protection Before Day One” Initiative Seeks Broadly Protective Influenza Vaccines

All Posts, BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a draft Request for Project Proposals (RPP) for “Protection Before Day One” (PBD1), Solicitation No. RRPV 26-08-PBD1. The initiative seeks to close a central pandemic preparedness gap: the time between identifying a novel pandemic influenza strain and deploying

BARDA’s “Protection Before Day One” Initiative Seeks Broadly Protective Influenza Vaccines Read More »

BioMaP’s REDD Program Outlines a Path to Repurpose Equipment for Drug Delivery

All Posts, BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), through its BioMaP Consortium, has outlined a proposed development effort to turn stored manufacturing equipment into a platform for emergency drug delivery. The Repurposing Equipment for Drug Delivery (REDD) draft Statement of Objectives (SOO) calls for a recipient to relocate, restore, and repurpose specialized equipment originally designed to

BioMaP’s REDD Program Outlines a Path to Repurpose Equipment for Drug Delivery Read More »

BARDA’s Draft New Vaccine Platforms RPP Signals a Major Push for Adaptable Medical Countermeasures

All Posts, BARDA, Life Sciences / By

Updated to reflect Draft Version 2, issued September 24, 2026. The revised draft expands eligible pathogen targets, clarifies platform maturity requirements, and adds a preference for U.S.-based companies and domestic performance. Requirements remain subject to change in the final RPP. The Biomedical Advanced Research and Development Authority (BARDA) has released the draft Request for Project

BARDA’s Draft New Vaccine Platforms RPP Signals a Major Push for Adaptable Medical Countermeasures Read More »

BARDA BioMaP Seeks Agile, Distributed Drug Manufacturing for Medical Countermeasures

All Posts, BARDA, Life Sciences / By

Updated to reflect Amendment 2, issued on October 16, 2026. The Biomedical Advanced Research and Development Authority (BARDA) has released has released a Request for Project Proposals through Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP), seeking U.S.-based teams that can develop and commercialize agile, distributed manufacturing capacity for medical countermeasures. RPP 26-13-EDM focuses on end-to-end production of

BARDA BioMaP Seeks Agile, Distributed Drug Manufacturing for Medical Countermeasures Read More »

BARDA's Growing Use of Hubs and Prize Competitions, Beyond SAM.gov

BARDA’s Growing Use of Hubs and Prize Competitions, Beyond SAM.gov

All Posts, BARDA, Industry News, Life Sciences / By

If you’ve been tracking Biomedical Advanced Research and Development Authority (BARDA) activity solely through SAM.gov, some opportunities may be easy to miss. Yes, traditional funding and contracting mechanisms, like BAAs and RFPs, continue to be pushed by BARDA – and will continue to do so for some time – but the agency is also making

BARDA’s Growing Use of Hubs and Prize Competitions, Beyond SAM.gov Read More »

Four Takeaways from the 2026 RRPV General Membership Meeting

All Posts, BARDA, Industry News, Life Sciences / By

The Rapid Response Partnership Vehicle (RRPV) consortium, through the Biomedical Advanced Research and Development Authority (BARDA), convenes government, industry, academic, nonprofit, and service-provider organizations working to accelerate medical countermeasures for emerging infectious diseases and other national preparedness priorities. EverGlade team members Laura Powell, PhD, PMP, and Richard Merlino, MBA attended last week’s General Membership Meeting

Four Takeaways from the 2026 RRPV General Membership Meeting Read More »

BARDA Previews TACTIC Program for Threat-Agnostic CBRN Therapeutics

All Posts, BARDA, Defense, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a pre-solicitation notice for a potential future project opportunity: TACTIC, or Threat-Agnostic CBRN Therapeutics. The anticipated effort would support development of therapeutics that address host dysregulation caused by chemical, biological, radiological, and nuclear, or CBRN, threats. BARDA is

BARDA Previews TACTIC Program for Threat-Agnostic CBRN Therapeutics Read More »

BARDA Releases RFP for Pandemic Influenza Vaccine Medical Countermeasures

All Posts, BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA) has released a new Request for Proposals, Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response. The solicitation seeks partners to support the development, manufacturing, stockpiling, regulatory readiness, and rapid deployment of influenza vaccine medical countermeasures during a pandemic or other public health emergency. BARDA’s objective is

BARDA Releases RFP for Pandemic Influenza Vaccine Medical Countermeasures Read More »

BARDA’s BioMaP-Consortium Seeks Vendor Managed Inventory Capabilities to Secure the Nation’s API Reserve

All Posts, BARDA, Emerging Technologies, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), has released Request for Project Proposals (RPP) 26-12-VMI, “Ensuring American Pharmaceutical Supply Chain Resilience through Vendor Managed Inventory Capabilities for Active Pharmaceutical Ingredients Used in Medical Countermeasure Finished Dose Form Drug Products.” Issued by the Administration for Strategic Preparedness and

BARDA’s BioMaP-Consortium Seeks Vendor Managed Inventory Capabilities to Secure the Nation’s API Reserve Read More »

BARDA’s Next Big Investment Play: Pandemic Preparedness And Domestic Manufacturing

All Posts, BARDA, Industry News, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA) has been telegraphing its priorities for years, but the latest cluster of moves makes the picture sharper: the U.S. is shifting from “buy vaccines when a crisis hits” to owning the infrastructure that keeps pandemic response on a hair trigger. Three signals stand out: A new pre‑solicitation

BARDA’s Next Big Investment Play: Pandemic Preparedness And Domestic Manufacturing Read More »

BARDA’s BioMaP Releases RPP on Domestic Manufacturing for Nitrile Gloves

All Posts, BARDA, Life Sciences / By

ASPR And BARDA Move To Close The Nitrile Glove Gap The Biomedical Advanced Research and Development Authority (BARDA), through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP‑Consortium), has released a new Request for Project Proposals (RPP 26‑09‑Gloves) focused on Expansion of Domestic Manufacturing Capacity for Nitrile Gloves. ASPR’s Center for Industrial Base Management and Supply Chain (IBMSC)

BARDA’s BioMaP Releases RPP on Domestic Manufacturing for Nitrile Gloves Read More »

Scroll to Top